Brigham and Women’s Hospital (BWH) is an international leader in virtually every area of medicine and has been the site of pioneering breakthroughs that have improved lives around the world. As a major teaching hospital of Harvard Medical School, BWH has a legacy of excellence that continues to grow year after year. US News and World Report consistently ranks BWH among the nation’s top 10 hospitals and in the top 10 for specialty areas that in 2014-2015 include cancer, cardiology and heartsurgery, gynecology, nephrology, and rheumatology.
Ariadne Labs is a unique collaboration between Brigham and Women’s
Hospital and the Harvard School of Public Health (HSPH) launched in
October 2012 with an ambitious goal: to produce research and discovery
that actually makes healthcare better everywhere. Ariadne Labs empowers
researchers to foster the sharing and development of cutting edge ideas
and real-time results. Its goal is to aid practitioners in managing the
complexity of increasing specialization and technology to consistently
provide effective, humane and affordable care for all. The Executive
Director of Ariadne Labs is BWH surgeon and well-known author and writer
Atul Gawande, M.D., M.P.H. Dr. Gawande’s research and
leadership focuses on the generation of systems innovations to transform
safety and quality in health care. He has been a staff writer for
The New Yorker magazine since 1998 and has written three bestselling books, won two National Magazine awards, and was a finalist for the National Book Award. His newest book, Being Mortal: Medicine and What Matters in the End, was selected by Amazon.com as one of the best books of 2014 and is currently ranked #1 on The New York Times Best Sellers list.